Meta Information
ID:tongkat-ali
Name:Tongkat Ali
Schema Version:2.4_uniform_evidence_2026_06_18
Created
2026-07-02T07:04:56Z
Model
phase-b-newfiles-claude-opus-4.8
Interactions
Target id:
/class/androgens
Target name:
Androgen/testosterone therapy
Severity:
minor
Interaction type:
synergistic
Nature:
relative
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Tongkat ali can modestly raise testosterone, adding to androgen therapy.
Actionable advice:
It is a good idea to monitor if combining with testosterone therapy, though the effect is modest.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Tongkat ali modestly increases endogenous testosterone; additive with androgens. Low-magnitude.
Label source:
Class inference
Action type:
monitor
Target id:
/condition/hormone-sensitive-cancer
Target name:
Hormone-sensitive cancers (prostate)
Severity:
moderate
Interaction type:
adverse
Nature:
conditional
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
By raising androgens, tongkat ali could theoretically stimulate hormone-sensitive (e.g., prostate) tumors.
Actionable advice:
It is best avoided with a history of, or high risk for, hormone-sensitive cancer.
Validation status:
validated_via_class_inference
Evidence tier:
tier_c
Evidence basis:
class_inference_summary
Evidence anchors:
Source url:
Established mechanism / class pharmacology (no single primary source quoted)
Exact phrase from label:
Raises androgens; precautionary in androgen-sensitive malignancy. Theoretical.
Label source:
Class inference
Action type:
avoid